The latest cancer news for cancer research. Inform yourselves about the newest technologies, best practices and studies in the field of cancer diseases and tumors.

• Encephalitis identified as rare toxicity of immunotherapy treatment July 22, 2019
  Researchers chronicling rare but serious toxicities that may occur with immune checkpoint inhibitors, the most widely prescribed class of immunotherapies.
• Targeting old bottleneck reveals new anticancer drug strategy July 22, 2019
  The enzyme ribonucleotide reductase is a bottleneck for cancer cell growth. Scientists have identified a way of targeting ribonucleotide reductase that may avoid the toxicity of previous approaches, informing focused drug discovery efforts.
• More colorectal cancer cases are being diagnosed in younger patients July 22, 2019
  Average age at diagnosis in the United States has decreased over the past decade.
• New deactivation mechanism for switch proteins detected July 22, 2019
  A new mechanism for the deactivation of switch proteins has been identified. Switch proteins such as Ras regulate many processes in the body and affect diseases such as cancer.
• Overstuffed cancer cells may have an Achilles' heel July 22, 2019
  In a study using yeast cells and data from cancer cell lines, scientists report they have found a potential weak spot among cancer cells that have extra sets of chromosomes, the structures that carry genetic material. The vulnerability, they say, is rooted in a common feature among cancer cells -- their high intracellular protein concentrations -- that make […]
• New technique helps create more personalized therapies for people with advanced cancers July 22, 2019
  Using an ultra-sensitive and high-throughput isolation technology, researchers were able to characterize and identify the neoantigens driving the antitumor responses in a patient.
• Genetic similarities of osteosarcoma between dogs and children July 19, 2019
  A bone cancer known as osteosarcoma is genetically similar in dogs and human children, according to the results of a new study. The findings could help break the logjam in the treatment of this deadly disease, which hasn't seen a significant medical breakthrough in nearly three decades.